News Details

View all news

Cognex Reports Less-Than-Fabulous Results for the Second Quarter of 2020

July 29, 2020

NATICK, Mass.--(BUSINESS WIRE)-- Cognex Corporation (NASDAQ:CGNX) today reported financial results for the second quarter of 2020. Table 1 below shows selected financial data for Q2-20 compared with Q2-19 and Q1-20, and for the six months ended June 28, 2020 compared with the same period in 2019. Notably, Cognex recorded significant restructuring and other charges, totaling over $42 million, in Q2-20 that reduced earnings for the quarter by $0.20 per diluted share.

Table 1

(Dollars in thousands, except per share amounts)

 

 

 

 

Revenue

 

 

Net
Income/(Loss)

Net
Income/(Loss)
per Diluted
Share

Non-GAAP
Net Income
per Diluted
Share*

Quarterly Comparisons

 

 

 

 

Current quarter: Q2-20

$169,097

$(1,142)

$(0.01)

$0.18

Prior year’s quarter: Q2-19

$199,047

$48,749

$0.28

$0.28

Change: Q2-19 to Q2-20

(15)%

(102)%

(104)%

(36)%

Prior quarter: Q1-20

$167,235

$20,477

$0.12

$0.11

Change: Q1-20 to Q2-20

1%

(106)%

(108)%

64%

Year-to-Date Comparisons

 

 

 

 

Six months ended June 28, 2020

$336,332

$19,335

$0.11

$0.29

Six months ended June 30, 2019

$372,531

$81,853

$0.47

$0.45

Change from first six months of 2019 to first six months of 2020

(10)%

(76)%

(77)%

(36)%

*Non-GAAP net income per diluted share excludes restructuring and other charges that occurred only in Q2-20 and tax adjustments for all periods presented. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.

“As we expected, the second quarter was very difficult for Cognex as it was for many companies around the world,” said Dr. Robert J. Shillman, Founder and Chairman of Cognex. “Because of the poor business conditions due to government-imposed shutdowns attributed to COVID-19, we found it necessary to implement significant changes to our company that, we believe, will put us in a stronger position going forward.”

“Few companies, including Cognex, are happy with their operating results this quarter,” said Robert J. Willett, Chief Executive Officer of Cognex. “However, we accomplished a lot by moving quickly to support customers and win business remotely, continue our product development schedules, and reconfigure our company for future growth. Machine vision remains a great business with substantial long-term growth potential, and we intend to continue leading the way as companies around the world resume their manufacturing efforts.”

“Order activity was strong during Q2 in both the consumer electronics and e-commerce markets, and we believe that bodes well for revenue in Q3. As a result, we expect to report growth next quarter on both a year-on-year and sequential basis despite tepid demand in the broader factory automation market,” concluded Mr. Willett.

Pre-tax Restructuring and Other Charges in Q2 2020

On May 26, 2020, the Board of Directors approved actions intended to reduce expenses and increase operating efficiencies. This included an 8% reduction in Cognex’s worldwide headcount, closure of leased office space, and reduced compensation for Chairman Dr. Shillman, CEO Mr. Willett, and the company’s other board members through the end of 2020. As a result of the restructuring, Cognex recorded a pre-tax charge of $14.8 million in Q2-20. Cognex also recorded pre-tax charges of $19.6 million for the impairment of intangible assets and $7.7 million for the write-down of excess and obsolete inventory in Q2-20 due to difficult business conditions the company is currently experiencing in many of its markets.

Details of the Quarter

Statement of Operations Highlights – Second Quarter of 2020

  • Revenue decreased by 15% from Q2-19 and increased 1% from Q1-20. As expected, Cognex’s revenue in Q2-20 was adversely impacted by deteriorating global economic conditions resulting from the COVID-19 pandemic. The decline in revenue year-on-year was due to substantially lower sales to customers in the automotive industry, which was the company’s largest market in both Q2-19 and Q1-20. Growth in logistics partially offset that weakness year-on-year and more than offset it on a sequential basis. The timing of revenue from consumer electronics contributed to the year-on-year decline.
  • Gross margin was 70% for Q2-20 compared with 74% for Q2-19 and 75% for Q1-20. The decrease in gross margin, both year-on-year and sequentially, was due to the pre-tax charge of $7.7 million for excess and obsolete inventory in Q2-20 noted above. Excluding that write-off, gross margin was 75% in Q2-20.
  • Research, Development & Engineering (RD&E) expenses increased by 8% from Q2-19 and decreased 15% from Q1-20. The year-on-year increase in RD&E spending reflects incremental costs associated with Sualab Co., Ltd. (Sualab), which Cognex acquired in Q4-19. The decrease in RD&E on a sequential basis was due to lower stock-based compensation expense.
  • Selling, General & Administrative (SG&A) expenses decreased by 12% from Q2-19 and 13% from Q1-20. The decline in SG&A spending year-on-year was due to lower travel and entertainment costs. The decrease in SG&A on a sequential basis was due to both lower stock-based compensation expense and reduced travel and entertainment costs.
  • As noted above, Cognex recorded a pre-tax restructuring charge of $14.8 million and a pre-tax charge of $19.6 million for the impairment of acquired intangible assets in Q2-20.
  • The effective tax rate in Q2-20 was a benefit of 51% compared with an expense of 14% in Q2-19 and an expense of 11% in Q1-20. Excluding the discrete tax adjustments summarized in Exhibit 2, the tax rate was a benefit of 19% compared with an expense of 17% and an expense of 17%, respectively. The tax rate excluding discrete tax adjustments increased to 19% in Q2-20 due to more of the company’s profits being earned and taxed in higher-tax jurisdictions.

Balance Sheet Highlights – June 28, 2020

  • Cognex’s financial position as of June 28, 2020 continued to be strong, with $896 million in cash and investments and no debt. In the first six months of 2020, Cognex generated $79 million in cash from operations and $48 million from the exercise of stock options. The company spent $51 million to repurchase its common stock and paid $19 million in dividends to shareholders. Cognex intends to continue to repurchase shares of its common stock pursuant to its existing stock repurchase program, subject to market conditions and other relevant factors.
  • Inventories decreased by approximately $7 million, or 12%, from the end of 2019 as a result of a higher provision for excess and obsolete inventory noted above.

Financial Outlook – Q3 2020

  • Given the degree of global uncertainty, Cognex widened its expected revenue range for Q3-20. The company is also assuming that business conditions continue in line with the current situation.
  • Cognex expects revenue for Q3-20 will be between $200 million and $220 million. This range represents growth both year-on-year and sequentially due to higher expected revenue from customers in the consumer electronics and logistics markets. However, Cognex is experiencing weak business conditions in its core factory automation market and expects that to continue for some time.
  • Gross margin for Q3-20 is expected to be in the mid-70% range.
  • The combined total of expenses for RD&E and SG&A, which excludes the restructuring and intangible impairment charges, is expected to be relatively flat with both Q2-20 and Q3-19.
  • The effective tax rate is expected to be 19%, excluding discrete tax items.

Non-GAAP Financial Measures

  • Exhibit 2 of this news release includes a reconciliation of certain financial measures from GAAP to non-GAAP. Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare Cognex results over multiple periods using the same methodology that management employs in its budgeting process and in its review of Cognex’s operating results. Non-GAAP presentations exclude the following: (1) stock-based compensation expense for calculating non-GAAP adjusted operating income and net income from continuing operations (because these expenses have no current effect on cash or the future uses of cash, and they fluctuate because of changes in Cognex’s stock price), and (2) certain one-time discrete events, such as restructuring charges, intangible asset impairment charges, excess and obsolete inventory charges, and tax adjustments (because these costs are outside of Cognex’s normal business operations and not used by management to assess Cognex’s operating results). Cognex also uses results on a constant-currency basis as one measure to evaluate performance. Constant-currency information compares results between periods as if the exchange rates had remained constant period-over-period. Cognex does not intend for non-GAAP financial measures to be considered in isolation, or as a substitute for financial information provided in accordance with GAAP.
  • The tax effect of items identified in the reconciliation is estimated by applying the effective tax rate to the pre-tax amount. However, if a specific tax rate or tax treatment is required because of the nature of the item and/or the tax jurisdiction where the item was recorded, the tax effect is estimated by applying the relevant specific tax rate or tax treatment, rather than the effective tax rate.
  • Analyst Conference Call and Simultaneous Webcast
  • Cognex will host a conference call today at 5:00 p.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 (or (201) 389-0911 if outside the United States). A replay will begin at 8:00 p.m. EDT today and will be available until 11:59 p.m. EDT on Saturday, August 1, 2020. The telephone number for the replay is (877) 660-6853 (or (201) 612-7415 if outside the United States). The access code for both the live call and the replay is 13705375.
  • A real-time audio broadcast of the conference call or an archived recording will be accessible on the Events & Presentations page of the Cognex Investor website: https://www.cognex.com/Investor.

About Cognex Corporation

Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.

Cognex is the world's leader in the machine vision industry, having shipped more than 2.3 million image-based products, representing over $7 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe and Asia. For details visit Cognex online at www.cognex.com.

Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on Cognex’s business and results of operations, customer order rates and timing of related revenue, future product mix, restructuring and other cost savings initiatives, research and development activities, investments, liquidity, strategic plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include (1) the impact, duration and severity of the COVID-19 pandemic; (2) current and future conditions in the global economy, including the impact of the COVID-19 pandemic and the imposition of tariffs or export controls; (3) the loss of, or curtailment of purchases by, a large customer; (4) the reliance on revenue from the consumer electronics or automotive industries; (5) the inability to penetrate the logistics industry and other new markets; (6) the inability to achieve significant international revenue; (7) fluctuations in foreign currency exchange rates and the use of derivative instruments; (8) information security breaches or business system disruptions; (9) the inability to attract and retain skilled employees; (10) the failure to effectively manage our growth; (11) the reliance upon key suppliers to manufacture and deliver critical components for our products; (12) the failure to effectively manage product transitions or accurately forecast customer demand; (13) the inability to design and manufacture high-quality products; (14) the technological obsolescence of current products and the inability to develop new products; (15) the failure to properly manage the distribution of products and services; (16) the inability to protect our proprietary technology and intellectual property; (17) our involvement in time-consuming and costly litigation; (18) the impact of competitive pressures; (19) the challenges in integrating and achieving expected results from acquired businesses, including the recent acquisition of Sualab; (20) potential impairment charges with respect to our investments or for acquired intangible assets or goodwill; (21) exposure to additional tax liabilities; and (22) potential disruptions to our business due to restructuring activities and the failure of such activities to generate the anticipated cost savings; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2019 and Form 10-Q for the fiscal quarter ended June 28, 2020. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.

Exhibit 1

 

COGNEX CORPORATION

Statements of Operations

(Unaudited)

Dollars in thousands, except per share amounts

 

Three-months Ended

Six-months Ended

 

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

 

 

 

 

 

 

Revenue

$

169,097

 

$

167,235

 

$

199,047

 

$

336,332

 

$

372,531

 

Cost of revenue (1)

 

50,320

 

 

41,200

 

 

50,967

 

 

91,520

 

 

97,251

 

Gross margin

 

118,777

 

 

126,035

 

 

148,080

 

 

244,812

 

 

275,280

 

Percentage of revenue

 

70

%

 

75

%

 

74

%

 

73

%

 

74

%

Research, development, and engineering expenses (1)

 

30,397

 

 

35,946

 

 

28,079

 

 

66,343

 

 

58,321

 

Percentage of revenue

 

18

%

 

21

%

 

14

%

 

20

%

 

16

%

Selling, general, and administrative expenses (1)

 

60,153

 

 

69,138

 

 

68,245

 

 

129,291

 

 

135,056

 

Percentage of revenue

 

36

%

 

41

%

 

34

%

 

38

%

 

36

%

Restructuring charges

 

14,798

 

 

 

 

 

 

14,798

 

 

 

Intangible asset impairment charges

 

19,571

 

 

 

 

 

 

19,571

 

 

 

Operating income (loss)

 

(6,142

)

 

20,951

 

 

51,756

 

 

14,809

 

 

81,903

 

Percentage of revenue

 

(4

)%

 

13

%

 

26

%

 

4

%

 

22

%

Foreign currency gain (loss)

 

336

 

 

(3,003

)

 

140

 

 

(2,667

)

 

(108

)

Investment and other income

 

3,494

 

 

5,046

 

 

5,079

 

 

8,540

 

 

10,911

 

Income (loss) before income tax expense (benefit)

 

(2,312

)

 

22,994

 

 

56,975

 

 

20,682

 

 

92,706

 

Income tax expense (benefit)

 

(1,170

)

 

2,517

 

 

8,226

 

 

1,347

 

 

10,853

 

Net income (loss)

$

(1,142

)

$

20,477

 

$

48,749

 

$

19,335

 

$

81,853

 

Percentage of revenue

 

(1

)%

 

12

%

 

24

%

 

6

%

 

22

%

 

 

 

 

 

 

Net income (loss) per weighted-average common and common-equivalent share:

 

 

 

 

 

Basic

$

(0.01

)

$

0.12

 

$

0.28

 

$

0.11

 

$

0.48

 

Diluted

$

(0.01

)

$

0.12

 

$

0.28

 

$

0.11

 

$

0.47

 

 

 

 

 

 

 

Weighted-average common and common-equivalent shares outstanding:

 

 

 

 

 

Basic

 

172,283

 

 

172,408

 

 

171,318

 

 

172,345

 

 

171,209

 

Diluted

 

172,283

 

 

175,602

 

 

175,448

 

 

175,499

 

 

175,528

 

 

 

 

 

 

 

Cash dividends per common share

$

0.055

 

$

0.055

 

$

0.050

 

$

0.110

 

$

0.100

 

Cash and investments per common share

$

5.18

 

$

4.92

 

$

5.05

 

$

5.18

 

$

5.05

 

Book value per common share

$

7.95

 

$

7.73

 

$

6.98

 

$

7.95

 

$

6.98

 

 

 

 

 

 

 

(1) Amounts include stock-based compensation expense, as follows:

 

 

 

 

 

Cost of revenue

$

363

 

$

354

 

$

329

 

$

717

 

$

780

 

Research, development, and engineering

 

2,401

 

 

5,366

 

 

3,550

 

 

7,767

 

 

8,017

 

Selling, general, and administrative

 

5,254

 

 

9,070

 

 

7,088

 

 

14,324

 

 

14,451

 

Total stock-based compensation expense

$

8,018

 

$

14,790

 

$

10,967

 

$

22,808

 

$

23,248

 

 

 

 

 

 

 

 

Exhibit 2

 

COGNEX CORPORATION

Reconciliation of Selected Items from GAAP to Non-GAAP

(Unaudited)

Dollars in thousands, except per share amounts

 

 

Three-months Ended

Six-months Ended

 

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

Adjustment for stock expense and tax benefit for stock exercises

Operating income (loss) (GAAP)

$

(6,142

)

$

20,951

 

$

51,756

 

$

14,809

 

$

81,903

 

Stock-based compensation expense

 

8,018

 

 

14,790

 

 

10,967

 

 

22,808

 

 

23,248

 

Operating income (Non-GAAP)

$

1,876

 

$

35,741

 

$

62,723

 

$

37,617

 

$

105,151

 

Percentage of revenue (Non-GAAP)

 

1

%

 

21

%

 

32

%

 

11

%

 

28

%

 

 

 

 

 

 

Net income (loss) (GAAP)

$

(1,142

)

$

20,477

 

$

48,749

 

$

19,335

 

$

81,853

 

Stock-based compensation expense

 

8,018

 

 

14,790

 

 

10,967

 

 

22,808

 

 

23,248

 

Tax effect on stock-based compensation expense

 

(1,277

)

 

(2,564

)

 

(1,813

)

 

(3,841

)

 

(4,035

)

Discrete tax benefit related to stock-based compensation

 

(4,413

)

 

(1,680

)

 

(1,248

)

 

(6,093

)

 

(3,978

)

Net income (Non-GAAP)

$

1,186

 

$

31,023

 

$

56,655

 

$

32,209

 

$

97,088

 

Percentage of revenue (Non-GAAP)

 

1

%

 

19

%

 

28

%

 

10

%

 

26

%

 

 

 

 

 

 

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

 

$

0.28

 

$

0.11

 

$

0.47

 

Per share impact of non-GAAP adjustments identified above

 

0.02

 

 

0.06

 

 

0.04

 

 

0.07

 

 

0.08

 

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.01

 

$

0.18

 

$

0.32

 

$

0.18

 

$

0.55

 

 

 

 

 

 

 

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

 

175,403

 

 

175,602

 

 

175,448

 

 

175,499

 

 

175,528

 

 

 

 

 

 

 

 

 

 

 

 

 

Exclusion of tax adjustments

Income (loss) before income tax expense (benefit) (GAAP)

$

(2,312

)

$

22,994

 

$

56,975

 

$

20,682

 

$

92,706

 

 

 

 

 

 

 

Income tax expense (benefit) (GAAP)

$

(1,170

)

$

2,517

 

$

8,226

 

$

1,347

 

$

10,853

 

Effective tax rate (GAAP)

 

(51

)%

 

11

%

 

14

%

 

7

%

 

12

%

 

 

 

 

 

 

Tax adjustments:

 

 

 

 

 

Discrete tax benefit related to stock-based compensation

 

4,413

 

 

1,680

 

 

1,248

 

 

6,093

 

 

3,978

 

Discrete tax benefit (expense) related to tax return filings and other

 

(3,267

)

 

(242

)

 

 

 

(3,509

)

 

3

 

Tax rate adjustment

 

(415

)

 

 

 

 

 

 

 

 

Income tax expense (benefit) (Non-GAAP)

$

(439

)

$

3,955

 

$

9,474

 

$

3,931

 

$

14,834

 

Effective tax rate (Non-GAAP)

 

(19

)%

 

17

%

 

17

%

 

19

%

 

16

%

 

 

 

 

 

 

Net income (loss) (Non-GAAP)

$

(1,873

)

$

19,039

 

$

47,501

 

$

16,751

 

$

77,872

 

Percentage of revenue (Non-GAAP)

 

(1

)%

 

11

%

 

24

%

 

5

%

 

21

%

 

 

 

 

 

 

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

 

$

0.28

 

$

0.11

 

$

0.47

 

Per share impact of non-GAAP adjustments identified above

 

 

 

(0.01

)

 

(0.01

)

 

(0.01

)

 

(0.03

)

Net income (loss) per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

(0.01

)

$

0.11

 

$

0.27

 

$

0.10

 

$

0.44

 

 

 

 

 

 

 

Diluted weighted-average common and common-equivalent shares outstanding (GAAP)

 

172,283

 

 

175,602

 

 

175,448

 

 

175,499

 

 

175,528

 

 

 

 

 

 

 

 

Exhibit 2

 

 

Three-months Ended

Six-months Ended

 

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

Exclusion of restructuring and other charges

Gross margin (GAAP)

$

118,777

 

$

126,035

 

$

148,080

 

$

244,812

 

$

275,280

 

Excess and obsolete inventory charges

 

7,718

 

 

1,065

 

 

933

 

 

8,783

 

 

1,713

 

Gross margin (Non-GAAP)

$

126,495

 

$

127,100

 

$

149,013

 

$

253,595

 

$

276,993

 

Percentage of revenue (Non-GAAP)

 

75

%

 

76

%

 

75

%

 

75

%

 

74

%

 

 

 

 

 

 

Operating income (loss) (GAAP)

$

(6,142

)

$

20,951

 

$

51,756

 

$

14,809

 

$

81,903

 

Excess and obsolete inventory charges

 

7,718

 

 

1,065

 

 

933

 

 

8,783

 

 

1,713

 

Restructuring charges

 

14,798

 

 

 

 

 

 

14,798

 

 

 

Intangible asset impairment charges

 

19,571

 

 

 

 

 

 

19,571

 

 

 

Operating income (Non-GAAP)

$

35,945

 

$

22,016

 

$

52,689

 

$

57,961

 

$

83,616

 

Percentage of revenue (Non-GAAP)

 

21

%

 

13

%

 

26

%

 

17

%

 

22

%

 

 

 

 

 

 

Net income (loss) (GAAP)

$

(1,142

)

$

20,477

 

$

48,749

 

$

19,335

 

$

81,853

 

Excess and obsolete inventory charges

 

7,718

 

 

1,065

 

 

933

 

 

8,783

 

 

1,713

 

Restructuring charges

 

14,798

 

 

 

 

 

 

14,798

 

 

 

Intangible asset impairment charges

 

19,571

 

 

 

 

 

 

19,571

 

 

 

Tax effect on restructuring and other charges

 

(7,997

)

 

(181

)

 

(159

)

 

(8,199

)

 

(274

)

Net income (Non-GAAP)

$

32,948

 

$

21,361

 

$

49,523

 

$

54,288

 

$

83,292

 

Percentage of revenue (Non-GAAP)

 

19

%

 

13

%

 

25

%

 

16

%

 

22

%

 

 

 

 

 

 

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

 

$

0.28

 

$

0.11

 

$

0.47

 

Per share impact of non-GAAP adjustments identified above

 

0.20

 

 

 

 

 

 

0.20

 

 

 

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.19

 

$

0.12

 

$

0.28

 

$

0.31

 

$

0.47

 

 

 

 

 

 

 

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

 

175,403

 

 

175,602

 

 

175,448

 

 

175,499

 

 

175,528

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-months Ended

Six-months Ended

 

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

Exclusion of restructuring and other charges and tax adjustments

 

 

 

 

 

 

Net income (loss) (GAAP)

$

(1,142

)

$

20,477

 

$

48,749

 

$

19,335

 

$

81,853

 

Excess and obsolete inventory charges

 

7,718

 

 

1,065

 

 

933

 

 

8,783

 

 

1,713

 

Restructuring charges

 

14,798

 

 

 

 

 

 

14,798

 

 

 

Intangible asset impairment charges

 

19,571

 

 

 

 

 

 

19,571

 

 

 

Tax effect on restructuring and other charges

 

(7,997

)

 

(181

)

 

(159

)

 

(8,199

)

 

(274

)

Tax adjustments

 

(731

)

 

(1,438

)

 

(1,248

)

 

(2,584

)

 

(3,981

)

Net income (Non-GAAP)

$

32,217

 

$

19,923

 

$

48,275

 

$

51,704

 

$

79,311

 

Percentage of revenue (Non-GAAP)

 

19

%

 

12

%

 

24

%

 

15

%

 

21

%

 

 

 

 

 

 

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

 

$

0.28

 

$

0.11

 

$

0.47

 

Per share impact of non-GAAP adjustments identified above

 

0.19

 

 

(0.01

)

 

 

 

0.18

 

 

(0.02

)

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.18

 

$

0.11

 

$

0.28

 

$

0.29

 

$

0.45

 

 

 

 

 

 

 

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

 

175,403

 

 

175,602

 

 

175,448

 

 

175,499

 

 

175,528

 

 

 

 

 

 

 

 

Exhibit 3

COGNEX CORPORATION

Balance Sheets

(Unaudited)

Dollars in thousands

 

June 28, 2020

December 31, 2019

Assets

 

 

Cash and investments

$

896,192

$

845,353

Accounts receivable

 

111,671

 

103,447

Inventories

 

52,953

 

60,261

Property, plant, and equipment

 

83,936

 

89,443

Operating lease assets

 

25,819

 

17,522

Goodwill and intangible assets

 

259,773

 

282,935

Deferred tax assets

 

443,732

 

449,519

Other assets

 

60,788

 

37,455

 

 

 

Total assets

$

1,934,864

$

1,885,935

 

 

 

Liabilities and Shareholders' Equity

 

 

Accounts payable and accrued expenses

$

84,263

$

70,065

Deferred revenue and customer deposits

 

46,738

 

14,432

Operating lease liabilities

 

28,836

 

17,973

Income taxes

 

67,169

 

93,009

Deferred tax liabilities

 

326,295

 

332,344

Other liabilities

 

5,085

 

2,402

Shareholders' equity

 

1,376,478

 

1,355,710

 

 

 

Total liabilities and shareholders' equity

$

1,934,864

$

1,885,935

 

 

Susan Conway
Investor Relations
+1 508-650-3353
Susan.conway@cognex.com

Source: Cognex Corporation

Categories: Press Releases
View all news